Viorele Kit
Product Images NDC 68462-318

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Viorele (NDC 68462-318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure

Chemical structures of Desogestrel and Ethinyl Estradiol are shown. Desogestrel structure includes a steroid backbone with molecular formula C22H30O. Ethinyl Estradiol structure features a steroid nucleus with a hydroxyl group and molecular formula C20H24O2. Both are active ingredients in VIORELE.*

FDA Label Image

Carton (Carton)

Packaging label for VIORELE kit containing Desogestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.02 mg and Ethinyl Estradiol Tablets, USP 0.01 mg by Glenmark Pharmaceuticals Inc. The box indicates 3 blisters each with 28 tablets and includes storage instructions and manufacturer details. The label states Rx only and provides caution about medication safety and patient labeling.*

FDA Label Image

Figure 1

A forest plot titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' showing effect estimates (OR/RR) from several studies measuring breast cancer risk with ever or current use of combined oral contraceptives. The chart includes seven studies with points and confidence intervals plotted along a horizontal axis ranging from -1.5 to 2 for effect estimates.*

FDA Label Image

Table Iii: Circulatory Disease Mortality Rates Per 100,000 Woman-years By Age, Smoking Status, And Oral Contraceptive Use (Image 02)

A bar chart showing mortality rate (number of deaths per 100,000 woman-years) by age group (15-24, 25-34, 35-44, 45-) and smoking status. The categories compared are ever-users (non-smokers and smokers) and controls (non-smokers and smokers). Mortality rates increase with age, with the highest rates observed in ever-users who smoke in the 45 and older group.*

FDA Label Image

Blister Card Tablet Placement Example Graphic (Image 03)

An example diagram of a 28 pill pack illustrating the weekly schedule for taking tablets. The diagram shows white to off-white tablets for the first three weeks, light yellow to yellow tablets in week four, and pale green to yellowish green tablets during the last days of week four. Days of the week and week numbers are labeled with directional arrows indicating the order of tablet use.*

FDA Label Image

Day Label Sticker Placement Example Graphic (Image 04)

An instructional diagram showing a hand peeling off a day label strip to place on a calendar-style dosing card for VIORELE Desogestrel and Ethinyl Estradiol Tablets. The card is divided into four weeks, with circular placeholders for tablets and arrows indicating the direction for daily use. The diagram includes directions to place the correct day label at the top for dosing guidance.*

FDA Label Image

Blister Card Tablet Placement Example Graphic (Image 05)

An example diagram of a 28 Pill Pack for VIORELE, a kit containing Desogestrel and Ethinyl Estradiol tablets. It shows four weeks of circular pill positions arranged in rows for days Sunday through Saturday. Lines and labels indicate white to off-white tablets, light yellow to yellow tablets, and pale green to yellowish-green tablets.*

FDA Label Image

Day Label Sticker Placement Example Graphic (Image 06)

Instructional diagram showing a hand peeling a day-of-week label strip to place on a four-week oral tablet blister pack. The pack includes circular tablet slots arranged in four rows labeled WEEK 1 through WEEK 4, with arrows indicating the direction to take the tablets. The diagram emphasizes placing the correct day label on the pack to track daily dosing of Desogestrel and Ethinyl Estradiol tablets.*

FDA Label Image

Glenmark Logo (Image 07)

FDA Label Image

Glenmark Logo (Image 08)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.